Recearch for the role of the action of GLP-1 on normal glucose tolerance

Recearch for the role of the action of GLP-1 on normal glucose tolerance - Recearch for the role of the action of GLP-1 on normal glucose tolerance

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006858

Enrollment

Registered

2011-12-07

Start date

2012-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal glucose tolerance

Interventions

[exenatide] subcutaneous injection of exenatide 5 ug, 30 min before 75gOGTT. [liraglutide] subcutaneous injection ofliraglutide 0.9 mg, 10hr before 75gOGTT.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Normal glucose torerance

Exclusion criteria

Exclusion criteria: ad lib blood glucose >= 200 mg/dl hypersensitivity for the drugs pregnancy or the possibility HbA1c >= 6.1% severe renal dysfunction and liver function Considering unsuitable for this research with other reasons

Design outcomes

Primary

Measure	Time frame
serum blood glucose,insulin,CPR,gulucagon which are obtain from OGTT Time:0,5,10,15,30,60,90,120,150,180 min	—

Countries

Japan

Contacts

Public ContactYushi Hirota

Kobe University Graduate School of Medicine Division of Diabetes and Enocrinology

hirota@med.kobe-u.ac.jp078-382-5861

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026